Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05066113 · ClinicalTrials.gov registry record · NA

Feasibility Study on Radiofrequency-Based Selective Electrothermolysis to Investigate Its Effects on Human Skin

A NA study of Healthy Volunteers and Hidradenitis Suppurativa, sponsored by Johns Hopkins University.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT05066113 is a NA study of Healthy Volunteers and Hidradenitis Suppurativa that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 50 participants, below the 482-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05066113, a NA study of Healthy Volunteers and Hidradenitis Suppurativa, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This research is being done to assess the effect of radiofrequency (RF)-based treatment on skin and skin conditions.

Interventions

  • DEVICE Radiofrequency-Based treatment

Study Locations (1)

Maryland

  • Johns Hopkins School of Medicine - Baltimore

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2017-08-15
Est. Completion 2028-08
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT05066113

The ClinicalTrials.gov registry entry for NCT05066113 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 482-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (90% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Healthy Volunteers appearing as the primary indexed condition, and to 1 intervention - of which Radiofrequency-Based treatment is the first listed.

NCT05066113 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT05066113 about?

NCT05066113 is a clinical study titled "Feasibility Study on Radiofrequency-Based Selective Electrothermolysis to Investigate Its Effects on Human Skin". This research is being done to assess the effect of radiofrequency (RF)-based treatment on skin and skin conditions.

What is the current status of trial NCT05066113?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2017-08-15. Estimated completion is 2028-08.

What conditions does trial NCT05066113 study?

This clinical trial studies the following conditions: Healthy Volunteers, Hidradenitis Suppurativa.

What interventions are being tested in trial NCT05066113?

The interventions under investigation include: Radiofrequency-Based treatment (DEVICE).

Who is sponsoring clinical trial NCT05066113?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05066113 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Volunteers

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.